U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 215245
Company: BIOCON PHARMA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription AP1 No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/11/2026 ORIG-1 Approval STANDARD

Label is not available on this site.

LIRAGLUTIDE

SOLUTION;SUBCUTANEOUS; 18MG/3ML (6MG/ML)
TE Code = AP1

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription No AP1 215245 BIOCON PHARMA
LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription No AP1 215503 HIKMA
LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription No AP1 215421 LUPIN LTD
LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription No AP1 218115 NANJING KING FRIEND
LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription No AP1 217590 ORBICULAR
VICTOZA LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION;SUBCUTANEOUS Prescription Yes AP1 022341 NOVO NORDISK INC
Back to Top